Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Game-Changers in Western Blotting and Protein Analysis

Game-Changers in Western Blotting and Protein Analysis

An interview with Ramya Prabakaran & Melody Chang from GenScript, discussing the major challenges for researchers carrying out western blotting, and how GenScript’s automated systems are making the technique less time-consuming and more reliable.

How are GenScript involved in neurobiological research?

GenScript offers a wide range of catalog reagents, including cytokines, antibodies as well as peptides, for different areas of neuroscience research. Our MonoRab™ technology generates high-quality rabbit monoclonal antibodies which yield excellent results for Immunohistochemistry (IHC). We design and develop devices with the aim of making research easy.

Antibody - typically used in Western blotting - Tatiana ShepelevaTatiana Shepeleva | Shutterstock

What are the biggest challenges for researchers when conducting a western blot?

Although western blotting is the gold standard, it can be a very time-consuming technique. A typical western workflow can take up to a day or two to complete and get results.

There are also lots of steps involved in western blotting that allow for human error. Unfortunately, due to the nature of the technique, it is often impossible to know that there has been an error until you have imaged the blot.

How are GenScript working to reduce the amount of time it takes to conduct a western blot?

GenScript strives to streamline laboratory protocols so that researchers can attain reliable and reproducible results without compromising time.

For example, eStain L1 is an automated protein staining system developed by GenScript that stains and de-stains 2 mini gels in less than 10 minutes. It also boasts protein staining results that are equivalent or better to traditional staining methods.

Traditional coomassie staining can be time-consuming and messy but eStain L1 offers superior sensitivity compared to conventional methods and can detect as low as 12.5 ng of protein.

We recently launched our eBlot L1 ; the first fast, wet transfer system on the market. Researchers can achieve complete transfer efficiency in 9-17 minutes. Using this system, one of our customers was able to transfer 1200kD in 20 minutes!

Prior to the eBlot, they were performing overnight transfers using the traditional wet tank blotting system. Not only did our system save his lab valuable time, he was also able to obtain superior results in under 20 minutes.

As a world leader in protein analysis, what’s next for the company?

Over 90% of researchers still perform their westerns manually. Even though there are a few automated systems on the market, our research found that they are quite expensive, produce inconsistent results, and didn’t necessarily save researchers time.

We have taken all of this feedback into account and are working on a new automated system that alleviates these issues.

Where can readers find more information?

About GenScript

GenScript is proud to serve the research community since 2002. For the last 16 years, we’ve had the honor of being a reliable partner for life science research and drug discovery industry. Fifteen years of innovation and expertise has allowed GenScript to develop a comprehensive catalog of services and products.

As the world’s leading CRO, GenScript offers a complete list of life science research products and services. Our products include: a broad range of validated catalog antibodies, protein electrophoresis gels and reagents, CRISPR/molecular biology products and more.

Our services include: gene synthesis, custom monoclonal and polyclonal antibody generation, custom protein expression and purification, custom peptide synthesis, and custom cell line development. In addition, GenScript provides preclinical drug development services including in vitro pharmacology, in vivo pharmacology, and antibody/protein engineering services.

At GenScript, we are focused on improving human and animal health by enabling scientists to expedite life science and biomedical research. Powered by innovation, GenScript aims to make scientific research accessible by providing the essential tools necessary to tackle complex problems. We are constantly developing innovative products that incorporate the lastest technologies to address the challenges that researchers face today.

For more information, please visit www.genscript.com or call us at 732-885-9188.

Tagged with:

About author

Related Articles